Disease · fungal

Naemacyclus needle cast

Naemacyclus fimbriatus

Description

Naemacyclus needle cast is a fungal disease affecting various pine species, primarily caused by the pathogen Naemacyclus fimbriatus (often referred to as Cyclaneusma minus). This fungus targets the needles of pine trees, leading to premature needle drop, reduced photosynthetic capacity, and overall weakening of the host tree.

The disease is characterized by the appearance of yellow, mottled spots on older needles, which gradually turn brown or reddish-brown. As the infection advances, the entire needle may become necrotic and fall prematurely. During periods of high humidity, the fungus produces small, cream-colored, lens-shaped fruiting bodies that erupt through the epidermis of the needles.

Development and spread of the pathogen are highly dependent on moisture levels and temperature. Spores are disseminated by rain splash and wind currents, facilitating the infection of healthy foliage in the vicinity. The disease tends to be more severe in dense, poorly ventilated stands, plantations, or nurseries where microclimatic conditions favor fungal spore germination.

The impact of Naemacyclus needle cast is significant in terms of forest productivity and tree health. Chronic infection results in substantial foliage loss, which directly limits the tree's ability to produce energy, ultimately leading to stunted growth, reduced timber quality, and an increased susceptibility to secondary stressors, such as bark beetle infestations and drought.

Effective management requires a combination of silvicultural practices and chemical interventions. Key measures include:

  • Maintaining proper spacing between trees to improve air circulation and reduce humidity within the canopy.
  • Sanitation pruning and removal of heavily infected litter to reduce the local inoculum source.
  • Application of protective fungicides in nurseries or high-value landscapes during the peak infection periods when weather conditions are wet.
Marketplace

Products · 0

Community

Discussion

No discussions yet — be the first.